5 Biotechs With the Most Upside This Earnings Cycle
Despite a modest erosion to fundamentals and sector headwinds, Jefferies does not anticipate any dramatic earnings misses, which could help sentiment continue to turn around.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 218
3 Hot Biotechs Highlight Jefferies Growth Stocks to Buy This Week
This week's top U.S. growth calls from the analysts at Jefferies focus on companies that have some outstanding upside potential, including the following three leading biotech stocks.
Key Analyst Sees Huge Catalyst in Depomed Patent Suit
At the end of March, a district court granted the request from Depomed and lifted the stay of its patent infringement suit against Purdue.
Why Aldeyra Therapeutics Could Have Exponential Upside
Not only does Aldeyra Therapeutics have a good cash position, but it also it has a strong pipeline as well. One key analyst has decided to weigh in on the firm and where it…
Top 6 Biopharma Movers of the Past Week
Over the past week, Opko Health, Acadia Pharmaceuticals and a few other biotech companies made impressive runs.
Akari Therapeutics Soars on Positive Preliminary Results
Akari Therapeutics has announced preliminary results from the first paroxysmal nocturnal hemoglobinuria patient treated with subcutaneously administered Coversin.
Regeneron Rises on Positive Top-Line Results
Regeneron Pharmaceuticals has announced that two Phase 3 studies evaluating investigational dupilumab in adult patients with inadequately controlled moderate-to-severe atopic dermatitis met their primary endpoints.
Will Theranos Valuation Go to Zero?
High-tech blood testing company Theranos may be the first big unicorn that has a drop in valuation to zero.
Genocea Breaks Out With Very Positive Mid-Stage Results
Genocea Biosciences soared early on Thursday, following the release of positive data from its mid-stage genital herpes clinical trial.
Opko Health Stumbles Over FDA Letter
Opko Health saw its shares slide in Wednesday’s regular trading session following the release of a complete response letter from the FDA.
ContraVir Pharma Falls on Secondary Offering Pricing
ContraVir Pharmaceuticals stock shot up following positive results from a hepatitis B study earlier this week, but now it is back down after the pricing of a secondary offering was announced.
Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts
Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the sentiment may be less than stellar now, massive drug pricing changes anytime soon are…
Acadia Posts Big Win With FDA Approval
Acadia Pharmaceuticals saw its shares on the rise again this week following an incredibly positive FDA vote on its Parkinson's treatment.
SEC Charges Aveo With Misleading Investors
The SEC has announced fraud charges against Aveo Pharmaceuticals and three former executives for misleading investors.
ContraVir Pharma Takes Off on Positive Results
ContraVir Pharmaceuticals led the bulls early on Tuesday following the release of positive hepatitis B results.